Dunlevie Maternal-Fetal Medicine Center Research Seed Grant Fall 2026
Internal — Stanford University only
Stanford University's Dunlevie Seed Grant funds research driving innovation in maternal-fetal medicine, from basic science to clinical and population health advances.
Funder: Stanford University
Due Dates: Fall 2026 (application open now; funding period Jan 1, 2027 – Dec 31, 2027)
Funding Amounts: $35,000 per award; 1-year project duration
Summary: Supports innovative research advancing maternal-fetal medicine in discovery, diagnosis, therapy, trials, and epidemiology.
Key Information: Only Stanford faculty (UML, UTL, NTL-Research, CE, or Instructor) are eligible; one submission per applicant per cycle.
Description
The Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation and Clinical Impact at Stanford University offers a Seed Grant for Fall 2026. This program aims to catalyze new advances in maternal-fetal medicine by supporting pioneering research in four core areas: basic science discovery, prenatal diagnosis and fetal therapy, clinical trials in obstetrics and maternal-fetal medicine, and perinatal epidemiology and population health. The initiative encourages projects that push the boundaries of maternal-fetal science and promote a continuum from discovery to clinical implementation.
